← back to search

Deborah Kuk

Inspire Institute · US
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Sarcoma Diagnosis and Treatment, Immune cells in cancer, and Cardiac tumors and thrombi.
h-index
47
citations
8,198
works
124
NIH funding
primary concept
email

Recent publications

Extracting Quality of Life Information from Forum Posts Using Open-Source Large Language Models: Feasibility Study (Preprint)
2026cited by 0position: contributordoi
Extracting Quality of Life Information of Patients Diagnosed With Breast Cancer From Health Care Online Forum Posts: Data Feasibility Study.
2026cited by 0position: contributordoi
Extracting Quality of Life Information from Healthcare Online Forum Posts: A Feasibility Study with Breast Cancer Patients (Preprint)
2025cited by 0position: contributordoi
Quality of life and healthcare resource utilization among adult patients with short bowel syndrome: A mixed‐methods study leveraging an integrated database
Nutrition in Clinical Practice 2025cited by 0position: contributordoi
Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test
Gastroenterology 2023cited by 19position: middledoi
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Nature 2017cited by 1,637position: middledoi
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome
Annals of Surgical Oncology 2017cited by 69position: middledoi
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma
Annals of Surgery 2016cited by 490position: middledoi
The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma
Cancer 2016cited by 301position: middledoi
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer
Thyroid 2016cited by 227position: middledoi
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
The Oncologist 2016cited by 200position: firstdoi
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy
Annals of Surgical Oncology 2016cited by 88position: middledoi
Near universal detection of alterations in <scp><i>CTNNB1</i></scp> and <scp>Wnt</scp> pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis
Genes Chromosomes and Cancer 2015cited by 168position: middledoi
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
European Journal of Cancer 2015cited by 95position: middledoi
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
Human Pathology 2014cited by 292position: middledoi
Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
Cancer Immunology Research 2014cited by 140position: middledoi
Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes
Cancer Immunology Research 2014cited by 135position: middledoi
Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma
Annals of Surgical Oncology 2014cited by 134position: middledoi
Model selection in competing risks regression
Statistics in Medicine 2013cited by 125position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2025–2026)Jedd D. Wolchok · Cornell University4 papers (2014–2016)David Maria Schmidt · Bielefeld University3 papers (2025–2026)Philipp Cimiano · DFG3 papers (2025–2026)Brian Chen · 3 papers (2025–2026)Katherine S. Panageas · Bayer (Germany)3 papers (2014–2016)Li‐Xuan Qin · Memorial Sloan Kettering Cancer Center3 papers (2014–2015)Michael A. Postow · Memorial Sloan Kettering Cancer Center3 papers (2014–2016)Alexander N. Shoushtari · Humboldt-Universität zu Berlin3 papers (2014–2016)Mithat Gönen · Centre de Recherche Épidémiologie et Statistique3 papers (2014–2017)Mary Louise Keohan · Memorial Sloan Kettering Cancer Center2 papers (2014–2015)Sandra P. D’ Angelo · Memorial Sloan Kettering Cancer Center2 papers (2014–2015)Richard D. Carvajal · Northwell Health2 papers (2014–2016)Jianda Yuan · Merck & Co., Inc., Rahway, NJ, USA (United States)2 papers (2014–2014)Peter J. Allen · Duke University2 papers (2016–2017)Andreas Hinz · University Medical Center2 papers (2025–2026)Valmeek Kudesia · Inspire Institute2 papers (2025–2026)Raoul Schubert · 2 papers (2025–2026)Phillip Wong · Hudson Institute of Medical Research2 papers (2014–2014)Daniel G. Coit · Weill Cornell Medicine2 papers (2014–2016)